Ziqi Ye

843 total citations
47 papers, 612 citations indexed

About

Ziqi Ye is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ziqi Ye has authored 47 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ziqi Ye's work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer-related molecular mechanisms research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Ziqi Ye is often cited by papers focused on Pancreatic and Hepatic Oncology Research (4 papers), Cancer-related molecular mechanisms research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Ziqi Ye collaborates with scholars based in China, Bangladesh and United States. Ziqi Ye's co-authors include Yuefeng Rao, Zixue Xuan, Hongyu Yang, Jie Chen, Lin Li, Xiuhua Wu, Xin Li, Qingwei Zhao, Yijia Lou and Guobing Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Ziqi Ye

46 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ziqi Ye China 16 282 153 77 74 63 47 612
Xingchen Liu China 17 342 1.2× 127 0.8× 102 1.3× 86 1.2× 30 0.5× 67 838
Wanle Hu China 15 219 0.8× 149 1.0× 51 0.7× 46 0.6× 58 0.9× 22 508
Vibha Singh India 21 492 1.7× 174 1.1× 111 1.4× 74 1.0× 49 0.8× 69 941
Mohammed Nader Shalaby Egypt 16 333 1.2× 271 1.8× 113 1.5× 69 0.9× 70 1.1× 41 1.0k
Yu-Chu Su Taiwan 15 297 1.1× 108 0.7× 60 0.8× 50 0.7× 114 1.8× 18 605
Mohd M. Khan United States 12 322 1.1× 92 0.6× 43 0.6× 80 1.1× 63 1.0× 23 650
Sau Har Lee Malaysia 13 314 1.1× 123 0.8× 45 0.6× 59 0.8× 52 0.8× 34 731
Omar Al‐Obeed Saudi Arabia 16 259 0.9× 167 1.1× 61 0.8× 75 1.0× 39 0.6× 36 622
Vivek Kaushik United States 16 267 0.9× 129 0.8× 129 1.7× 71 1.0× 46 0.7× 35 586

Countries citing papers authored by Ziqi Ye

Since Specialization
Citations

This map shows the geographic impact of Ziqi Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziqi Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziqi Ye more than expected).

Fields of papers citing papers by Ziqi Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziqi Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziqi Ye. The network helps show where Ziqi Ye may publish in the future.

Co-authorship network of co-authors of Ziqi Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Ziqi Ye. A scholar is included among the top collaborators of Ziqi Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziqi Ye. Ziqi Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ye, Ziqi, et al.. (2025). A comprehensive evaluation of ALK inhibitors in the first-line treatment of patients with ALK-positive non-small cell lung cancer. SHILAP Revista de lepidopterología. 2(1). 100025–100025. 1 indexed citations
3.
He, Yuqing, Ziqi Ye, Fei Zhu, et al.. (2023). Enantioselective Labeling of Zebrafish for D-Phenylalanine Based on Graphene-Based Nanoplatform. Molecules. 28(9). 3700–3700. 2 indexed citations
4.
Zhu, Shiming, Xiaoyi Chen, Qin Li, et al.. (2023). Hexamerin and allergen are required for female reproduction in the American cockroach, Periplaneta americana. Insect Science. 31(1). 186–200. 2 indexed citations
5.
6.
Jiang, Tao, et al.. (2023). Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. BMC Medical Genomics. 16(1). 105–105. 6 indexed citations
7.
Li, Xiaodong, Xia Wu, Qi Wang, et al.. (2022). Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL/6 mice. Phytomedicine. 104. 154321–154321. 41 indexed citations
8.
Ye, Ziqi, et al.. (2022). The Correlation Between Probiotics and Anxiety and Depression Levels in Cancer Patients: A Retrospective Cohort Study. Frontiers in Psychiatry. 13. 830081–830081. 10 indexed citations
9.
Ye, Ziqi, et al.. (2022). Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response. Frontiers in Oncology. 12. 990195–990195. 20 indexed citations
10.
Mao, Xiaohong, Qiang Ye, Guobing Zhang, et al.. (2021). Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer. World Journal of Surgical Oncology. 19(1). 29–29. 25 indexed citations
11.
12.
Si, Yang, Yu Huang, Ziqi Ye, Lu Li, & Yu Zhang. (2020). The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis. Frontiers in Pharmacology. 11. 817–817. 16 indexed citations
13.
Ye, Ziqi, et al.. (2020). Enhanced recovery after surgery (ERAS) might be a standard care in radical prostatectomy: a systematic review and meta-analysis. Annals of Palliative Medicine. 9(3). 746–758. 13 indexed citations
14.
Jiang, Saiping, Rongrong Wang, Lu Li, et al.. (2020). Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Frontiers in Medicine. 7. 347–347. 26 indexed citations
15.
Wang, Wei, Linqing Liu, Yucheng Zhou, et al.. (2019). Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer. International Journal of Oncology. 55(2). 405–414. 23 indexed citations
16.
Li, Xin, Xiuhua Wu, Hongyu Yang, et al.. (2019). A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer. Biomedicine & Pharmacotherapy. 117. 109072–109072. 81 indexed citations
17.
Liu, Linqing, Shibing Wang, Yanfei Shao, et al.. (2019). Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy. Biomedicine & Pharmacotherapy. 118. 109339–109339. 40 indexed citations
18.
Chen, Zhe, Xin Huang, Hongyu Yang, et al.. (2010). Anti-tumor effects of B-2, a novel 2,3-disubstituted 8-arylamino-3H-imidazo[4,5-g]quinazoline derivative, on the human lung adenocarcinoma A549 cell line in vitro and in vivo. Chemico-Biological Interactions. 189(1-2). 90–99. 19 indexed citations
19.
Ou, Lili, Shuang Han, Wenbo Ding, et al.. (2010). Design, synthesis and 3D-QSAR study of cytotoxic flavonoid derivatives. Molecular Diversity. 15(3). 665–675. 16 indexed citations
20.
Ye, Ziqi, Zhe Chen, Wenteng Chen, et al.. (2009). XJW20, a novel oxoindole derivative, induces G2/M arrest and apoptosis selectively in K562 leukemia cell line. Chemico-Biological Interactions. 183(1). 133–141. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xingchen Liu Breakdown of academic impact, for papers by Wanle Hu Breakdown of academic impact, for papers by Vibha Singh Breakdown of academic impact, for papers by Mohammed Nader Shalaby Breakdown of academic impact, for papers by Yu-Chu Su Breakdown of academic impact, for papers by Mohd M. Khan Breakdown of academic impact, for papers by Sau Har Lee Breakdown of academic impact, for papers by Omar Al‐Obeed Breakdown of academic impact, for papers by Vivek Kaushik
Rankless by CCL
2026